BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/23/2021 6:43:04 AM | Browse: 383 | Download: 831
 |
Received |
|
2021-05-10 03:09 |
|
Peer-Review Started |
|
2021-05-10 03:12 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-05 13:59 |
|
Revised |
|
2021-06-18 23:32 |
|
Second Decision |
|
2021-07-12 03:37 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-07-12 06:30 |
|
Articles in Press |
|
2021-07-12 06:30 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-07-21 06:55 |
|
Typeset the Manuscript |
|
2021-08-20 03:25 |
|
Publish the Manuscript Online |
|
2021-08-23 06:43 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
PIK3CA mutation in non-metastatic triple-negative breast cancer as a potential biomarker of early relapse: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Guillermo Arturo Valencia, Patricia Rioja, Zaida Morante, Jhajaira M Araujo, Heberth Daniel Vallejos, Henry Guerra and Henry L Gomez |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Guillermo Arturo Valencia, MD, Medical Assistant, Medical Oncology, Instituto Nacional de Enfermedades Neoplásicas, Angamos Este Avenue 2520. Surquillo, Lima 15000, Peru. guillermo.valencia.mesias@gmail.com |
| Key Words |
Triple-negative breast cancer; PIK3CA mutation; Liquid biopsy; Early relapse; Biomarker; Case report |
| Core Tip |
This case report evaluates the detection of PIK3CA mutation in liquid biopsy and tumor tissue in a patient with locally-advanced triple-negative breast cancer after receiving conventional oncological therapy and its association with early relapse and progression disease. This case highlights the importance of detecting the PIK3CA mutation as a potential biomarker of early relapse. In addition, the PIK3CA mutation could lead to additional interventions to detect metastatic disease earlier in the follow-up. There is limited information of liquid biopsy studies after surgery. Furthermore, there is very limited data about trials of PIK3CA mutations in Peruvian patients with non-metastatic breast cancer. |
| Publish Date |
2021-08-23 06:43 |
| Citation |
Valencia GA, Rioja P, Morante Z, Araujo JM, Vallejos HD, Guerra H, Gomez HL. PIK3CA mutation in non-metastatic triple-negative breast cancer as a potential biomarker of early relapse: A case report. World J Clin Oncol 2021; 12(8): 702-711 |
| URL |
https://www.wjgnet.com/2218-4333/full/v12/i8/702.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v12.i8.702 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
